FLT3 anticorps (N-Term)
-
- Antigène Voir toutes FLT3 Anticorps
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp FLT3 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- FGTITNQDLP VIKCVLINHK NNDSSVGKSS SYPMVSESPE DLGCALRPQS
- Purification
- Affinity purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human FLT3
- Top Product
- Discover our top product FLT3 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- Antigène
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
- Autre désignation
- FLT3 (FLT3 Produits)
- Synonymes
- anticorps FLT3, anticorps B230315G04, anticorps CD135, anticorps Flk-2, anticorps Flk2, anticorps Flt-3, anticorps Ly72, anticorps wmfl, anticorps FLK-2, anticorps FLK2, anticorps STK1, anticorps fms related tyrosine kinase 3, anticorps FMS-like tyrosine kinase 3, anticorps fms-related tyrosine kinase 3, anticorps FLT3, anticorps Flt3
- Sujet
-
This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
Alias Symbols: FLK2, STK1, CD135, FLK-2
Protein Size: 952 - ID gène
- 2322
- NCBI Accession
- NM_004119, NP_004110
- Pathways
- Signalisation RTK
-